Tian Wei, Yang Li, Baozhu Li, Qian Xie, Yujing Huang, Zunge Wu, Haoqi Chen, Ying Meng, Lirui Liang, Ming Wang, Jiaxin Geng, Mengyu Lei, Jingli Shang, Sheng Guo, Zishan Yang, Huijie Jia, Feng Ren, Tiesuo Zhao
Melanoma, the most perilous form of skin cancer, is known for its inherent resistance to chemotherapy. Even with advances in tumor immunotherapy, the survival of patients with advanced or recurrent melanomas remains poor. Over time, melanoma tumor cells may produce excessive angiogenic factors, necessitating the use of combinations of angiogenesis inhibitors, including broad-spectrum options, to combat melanoma. Among these inhibitors, Endostatin is one of the most broad-spectrum and least toxic angiogenesis inhibitors...
December 15, 2023: International Immunopharmacology